Following a more cautious year 2016, the European public biotech sector observed an new increase of IPO and...
Analysis of European Biotech Companies on the Stock Markets
The BIOCOM report “Analysis of European Biotech Companies on the Stock Markets: US vs Europe” provides a complete overview of the current European public biotech sector. Ever since 2012, it covers all IPOs, follow-on financings, and secondary listings on all major stock market centres in Europe, as well as on Nasdaq.
Download the report 2018/2 published in the European Biotechnology Magazine (PDF)
Do you want to know more? Are you ready to become part of the European biotech picture? Contact us now:
Latest Updates
Biotech stocks in the US have recovered significantly in 2017. It corresponds with a number of successful...
Nearly a decade after the financial crisis, the European Life Science sector is flourishing again and has...
German pioneer in the field of immunotherapy
Berlin-based MOLOGEN AG is a pioneer for many reasons: Firstly,...
Share
